Waystar Early Adopter Program drives 86.5 percent recoupment match for Respiratory Technologies

Waystar Early Adopter Program drives 86.5 percent recoupment match for Respiratory Technologies
Waystar Early Adopter yields results

Waystar reported that its Early Adopter Program enabled Respiratory Technologies to achieve an 86.5 percent recoupment match after gaining early access to the Recoupment Manager solution.

The collaboration gave Respiratory Technologies the opportunity to provide real-world feedback, helping to shape the development of the product.

Waystar previously reported that its partnership with AnMed resulted in a $6.32 million revenue gain, according to company disclosures (link). The firm has also enabled Deaconess Health System to generate $13.3 million in revenue and cut observation rates by 3.8 percent using its platform (link). These outcomes add to the track record of financial and operational impacts following Waystar's technology deployments.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.